SCOTTSDALE, Ariz., April 24, 2023 /PRNewswire/ -- SimonMed is proud to announce we will offer GE HealthCare's radiopharmaceutical diagnostic tracer, DaTscan™ (Ioflupane I 123 injection), with ...
Ronald M. Schwartz, MD, of the Neurological Research Center at Hattiesburg Clinic, MS gives an interview about the DaTscan test, an imaging agent that was approved by the FDA this year. The DaTscan is ...
Parkinson’s disease (PD), the second-most common neurodegenerative disease, is characterized by motor and nonmotor symptoms. PD is often misdiagnosed; inappropriate treatment due to misdiagnosis has ...
VANCOUVER, Canada--(BUSINESS WIRE)--GE Healthcare today announced that results from three company studies utilizing DaTscan™ (Ioflupane I 123 Injection) in Parkinsonian Syndromes or the ...
The DaTscan, a special type of dopamine transporter imaging brain scan, may help doctors predict how a newly diagnosed patient’s Parkinson’s disease will progress, researchers from the University of ...
First patient dosed in Phase III clinical trial for PET radiopharmaceutical Next stage clinical study also proceeding for SPECT radiopharmaceutical Both imaging agents aim to assist in the evaluation ...
William Tank Hill used to be a professional welterweight fighter. Today he's fighting Parkinson's disease. Debora Bergstrom has it, too. The mother of three battles tremors, balance problems and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback